APA aipamena

Skrickova, J., Bortlicek, Z., Hejduk, K., Pesek, M., Kolek, V., Koubkova, L., . . . Salajka, F. (2014). O11. The results of gefitinib in front line treatment of Caucasian patients with NSCLC in the Czech Republic: Analysis according to activated mutations location. Transl Lung Cancer Res.

Chicago Style aipamena

Skrickova, Jana, et al. "O11. The Results of Gefitinib in Front Line Treatment of Caucasian Patients With NSCLC in the Czech Republic: Analysis According to Activated Mutations Location." Transl Lung Cancer Res 2014.

MLA aipamena

Skrickova, Jana, et al. "O11. The Results of Gefitinib in Front Line Treatment of Caucasian Patients With NSCLC in the Czech Republic: Analysis According to Activated Mutations Location." Transl Lung Cancer Res 2014.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.